The Effects of Transdermal Nicotine Therapy for Smoking Cessation on Depressive Symptoms in Patients with Major Depression

Anxiety sensitivity and anxiety and depressive symptoms in the prediction of early smoking lapse and relapse during smoking cessation treatment

“…For example, smokers with elevated levels of anxiety sensitivity and depressive symptoms may benefi t from intensive cognitive-behavioral strategies delivered prior to a quit attempt, such as interoceptive exposure, cognitive restructuring, and affective regulation strategies to decrease anxious and depressive responsivity and increase tolerance of negative affect, craving, and nicotine withdrawal symptoms to promote greater degrees of smoking abstinence. Although effort has been made to address anxiety sensitivity ( Zvolensky, Lejuez, Kahler, & Brown, 2003 ; ) and depressive problems ( Muñoz, Marín, Posner, & Pérez-Stable, 1997 ;Thorsteinsson et al, 2001 ) in smoking cessation treatments, integrated, multirisk factor approaches that target both anxiety sensitivity and depressive symptoms have yet to be developed. Such types of therapeutic strategies may represent a fertile area for further pursuit, particularly in the context of current trends toward the development of broadband approaches to the treatment of emotional disorders ( Barlow, Allen, & Choate, 2004 ).…”

Confronting a Neglected Epidemic: Tobacco Cessation for Persons with Mental Illnesses and Substance Abuse Problems

“…Both pharmacotherapy and counseling strategies need to be individualized to each patient's current mental health and substance abuse status, quit history, and level of nicotine dependency (120). Smokers need not be free of mental health symptoms to be motivated to quit (44,93,119). Generally, if interested in quitting they should be supported, unless there are ongoing medication changes or worsening psychiatric symptoms.…”

Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls

“…However, data from more recent epidemiological studies in both the USA (Breslau et al 2004) and Europe (John et al 2004) suggest that depressed smokers may not be more resistant to smoking-cessation treatments than smokers without a psychiatric diagnosis. In addition, two small-scale cessation studies have reported successful outcomes with currently depressed smokers (Muñoz et al 1997; Thorsteinsson et al 2001). Thus, greater understanding of the factors that maintain smoking in depression may help develop strategies to encourage more depressed smokers to quit successfully.…”